BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23895859)

  • 1. [Diagnostic value of (18)F-FDG PET/CT in extrapulmonary tuberculosis].
    Liu W; Li X; Yin J; Li X; Wang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1083-6. PubMed ID: 23895859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of extrapulmonary tuberculosis in (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography: experience from 39 cases].
    Liu GC; Gao S; Cai L; Chen QS
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Mar; 35(3):184-8. PubMed ID: 22781150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of soft-tissue lesions with (18)F-FDG PET/CT: initial results of a prospective trial.
    Leal AL; Etchebehere M; Santos AO; Kalaf G; Pacheco EB; Amstalden EM; Etchebehere EC
    Nucl Med Commun; 2014 Mar; 35(3):252-9. PubMed ID: 24300379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CT.
    Vorster M; Sathekge MM; Bomanji J
    Curr Opin Pulm Med; 2014 May; 20(3):287-93. PubMed ID: 24614238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response.
    Martinez V; Castilla-Lievre MA; Guillet-Caruba C; Grenier G; Fior R; Desarnaud S; Doucet-Populaire F; Boué F
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1180-5. PubMed ID: 22794271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
    Manabe O; Hattori N; Hirata K; Itoh K; Hosokawa M; Takahashi H; Oyama-Manabe N; Tamaki N
    J Nucl Med; 2013 May; 54(5):670-6. PubMed ID: 23516310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging-guided biopsy of (18)F-FDG-avid extrapulmonary lesions: do lesion location and morphologic features on CT affect the positive predictive value for malignancy?
    Nguyen ML; Gervais DA; Blake MA; Mueller PR; Sahani DV; Hahn PF; Uppot RN
    AJR Am J Roentgenol; 2013 Aug; 201(2):433-8. PubMed ID: 23883226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant disease as an incidental finding at ¹⁸F-FDG-PET/CT scanning in patients with granulomatous lung disease.
    Huber H; Hodolic M; Stelzmüller I; Wunn R; Hatzl M; Fellner F; Lamprecht B; Rubello D; Colletti PM; Gabriel M
    Nucl Med Commun; 2015 May; 36(5):430-7. PubMed ID: 25646704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low positive yield from routine inclusion of the brain in whole-body 18F-FDG PET/CT imaging for noncerebral malignancies: results from a large population study.
    Manohar K; Bhattacharya A; Mittal BR
    Nucl Med Commun; 2013 Jun; 34(6):540-3. PubMed ID: 23503001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging characteristics of extrapulmonary tuberculosis lesions on dual time point imaging (DTPI) of FDG PET/CT.
    Razak HR; Geso M; Abdul Rahim N; Nordin AJ
    J Med Imaging Radiat Oncol; 2011 Dec; 55(6):556-62. PubMed ID: 22141602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
    Du Y; Cullum I; Illidge TM; Ell PJ
    J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
    J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.
    Esen Akkas B; Gökaslan D; Güner L; Ilgin Karabacak N
    Rev Esp Med Nucl; 2011; 30(1):14-8. PubMed ID: 20702004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of 18F-FDG PET/CT uptake patterns in Waldeyer's ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx.
    Chen YK; Su CT; Chi KH; Cheng RH; Wang SC; Hsu CH
    J Nucl Med; 2007 Jan; 48(1):8-14. PubMed ID: 17204693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
    Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
    Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Umutlu L; Ruhlmann V; Rosenbaum-Krumme S; Antoch G; Buchbender C
    Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of (18)F-FDG PET/CT imaging plus serum tumor marker assays for pulmonary lesions and clinical significance of SUVmax].
    Zhang TM; Zhang LM; Liu Y; Zhang ZF; Wang CL
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2901-4. PubMed ID: 23328236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant tumor with false negative 18F-FDG PET image].
    Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.